CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients.

Autor: Zöphel, Sylvia1 (AUTHOR), Küchler, Nadja1 (AUTHOR), Jansky, Johanna1 (AUTHOR), Hoxha, Cora1 (AUTHOR), Schäfer, Gertrud1 (AUTHOR), Weise, Julius J.2 (AUTHOR), Vialle, Joanne1 (AUTHOR), Kaschek, Lea1 (AUTHOR), Stopper, Gebhard1 (AUTHOR), Eichler, Hermann3 (AUTHOR), Yildiz, Daniela4 (AUTHOR), Moter, Alina5,6 (AUTHOR), Wendel, Philipp5,6,7,8 (AUTHOR), Ullrich, Evelyn5,6,8 (AUTHOR), Schormann, Claudia9 (AUTHOR), Rixecker, Torben9 (AUTHOR), Cetin, Onur9 (AUTHOR), Neumann, Frank9 (AUTHOR), Orth, Patrick10 (AUTHOR), Bewarder, Moritz9 (AUTHOR)
Zdroj: Molecular Cancer. 9/28/2024, Vol. 23 Issue 1, p1-9. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje